KATHLEEN LUNDVALL: Open Payments
NPI 1508919879 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 12 payments from 5 companies in 2025. Trend: 2023 $1,656 · 2024 $1,043 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: INVEGA SUSTENNA, INGREZZA, ARISTADA, LYBALVI, UZEDY, ABILIFY MAINTENA.
Industry payments across SC — which companies pay providers there.
